RT Journal Article
SR Electronic
T1 Population-based Cross-sectional Analysis of the Epidemiology of the Surgical Correction of Hyperhidrosis in 1216 Patients over 11 years
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2021.09.14.21263594
DO 10.1101/2021.09.14.21263594
A1 Marcelo Fiorelli Alexandrino da Silva
A1 Andressa Cristina Sposato Louzada
A1 Marcelo Passos Teivelis
A1 Nickolas Stabellini
A1 Dafne Braga Diamante Leiderman
A1 José Ribas Milanez de Campos
A1 Edson Amaro, Junior
A1 Nelson Wolosker
YR 2021
UL http://medrxiv.org/content/early/2021/09/17/2021.09.14.21263594.abstract
AB Background Endoscopic thoracic sympathectomy is the definitive surgical treatment for hyperhidrosis, and a nationwide study suggested that it has been performed in a higher rate than which could have been expected due to climate characteristics, comparing to the national statistics.Objectives To study the epidemiology of sympathectomy to treat hyperhidrosis in São Paulo, the largest city in the Southeast.Design and setting population-based cross-sectional study.Methods data on sympathectomies to treat hyperhidrosis between 2008 and 2018 were assessed from the database of the Municipal Health Secretary of São Paulo, Brazil.Results 65.29% of the patients were female, 66.2% aged between 20 and 39 years and 37.59% had addresses registered outside São Paulo. 1216 procedures were performed in the city of São Paulo from 2008 to 2018, 78.45% of which in only two public hospitals. The number of procedures significantly declined over the years (p = 0.001). 71.63% of the procedures were associated with 2 to 3 days of hospital stay, only 78 intensive care unit days were billed and we did not observe any intra-hospital death.Conclusions sympathectomies for the treatment of HH were widely performed in the city of São Paulo (1216 procedures), mainly in young (20 -39 years) and female patients, with more than one third of the patients having addresses registered outside the city. This is a very safe surgery, with low need for intensive care units and no mortality in our series. There was a decreasing trend in the number of surgeries over the years.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNickolas Stabellini (author) received an undergraduate research scholarship from Institutional Scientific Initiation Scholarship Program (PIBIC). Process number 800996 2018 6, granted by the National Council for Scientific and Technological Development (CNPq), Brazil.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Ethics Committee of the Hospital Israelita Albert Einstein. Data are anonymous at DATASUS, therefore a waiver of informed consent was requested and granted by our institutional review board (process number 3067 17).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData is publicly available at datasus http://tabnet.saude.sp.gov.br/deftohtm.exe?tabnet/aih_rd2008.def